American Association for Cancer Research

SHERPA: Unknown

People

  1. Sirotnak
    Sirotnak
  2. Kris
    Kris
  3. Scher
    Scher
  4. Heelan
    Heelan
  5. Ginsberg
    Ginsberg
  6. Gonen
    Gonen
  7. Ng
    Ng
  8. Dunne
    Dunne
  9. Haimovitz-Friedman
    Haimovitz-Friedman
  10. Pfister
    Pfister

Groups

  1. Department of Medicine (18)
  2. Solid Tumor Oncology Division (18)
  3. Thoracic Oncology (16)
  4. Genitourinary Oncology Service (9)
  5. Biostatistics Service (5)
  6. Center for Pancreatic Cancer Research (5)
  7. Epidemiology and Biostatistics (5)
  8. Nursing (5)
  9. GSK Faculty (4)
  10. Radiology, Department of (4)
Search Within
  1. "Francis Sirotnak"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (18)
  2. Solid Tumor Oncology Division (18)
  3. Thoracic Oncology (16)
  4. Genitourinary Oncology Service (9)
  5. Biostatistics Service (5)
  6. Center for Pancreatic Cancer Research (5)

More Groups

People
  1. Francis Sirotnak (38)
  2. Mark Kris (16)
  3. Vincent Miller (12)
  4. Howard Scher (9)
  5. Yuhong She (9)
  6. William Tong (6)

More People

Years
  1. 2007 (1)
  2. 2006 (1)
  3. 2005 (1)
  4. 2003 (5)
  5. 2002 (2)
  6. 2001 (6)

More Years

Publications
  1. Clinical Cancer Research (22)
  2. Cancer Research (16)

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma
    Journal Article

    Toner, L. E.; Vrhovac, R.; Smith, E. A.; Gardner, J.; Heaney, M.; Gonen, M.; Teruya-Feldstein, J.; Sirotnak, F.; O'Connor, O. A.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel
    Journal Article

    Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX) plus docetaxel or paclitaxel in patients with advanced cancer
    Meeting Abstract

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Sharma, S.; Gomez, J.; Kris, M. G.; Ginsberg, M.; Baez, V.; Henry, R.; Tyson, L.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index
    Journal Article

    She, Y.; Lee, F.; Chen, J.; Haimovitz-Friedman, A.; Miller, V. A.; Rusch, V.; Kris, M. G.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • 10-Propargyl-10-deazaaminopterin: An antifolate with activity in patients with previously treated non-small cell lung cancer
    Journal Article

    Krug, L. M.; Azzoli, C. G.; Kris, M. G.; Miller, V. A.; Khokhar, N. Z.; Tong, W.; Ginsberg, M. S.; Venkatraman, E.; Tyson, L.; Pizzo, B.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase inhibitor flavopiridol potentiates γ-irradiation-induced apoptosis in colon and gastric cancer cells
    Journal Article

    Jung, C.; Motwani, M.; Kortmansky, J.; Sirotnak, F. M.; She, Y.; Gonen, M.; Haimovitz-Friedman, A.; Schwartz, G. K.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer
    Journal Article

    Sirotnak, F. M.; She, Y.; Lee, F.; Chen, J.; Scher, H. I.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells
    Journal Article

    Motwani, M.; Sirotnak, F. M.; She, Y.; Commes, T.; Schwartz, G. K.
    Cancer Research (2002)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: